[1] Arroyo V, Ginès P, Gerbes A L, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis[J]. International Ascites Club. Hepatology, 1996, 23(1): 164-176. [2] Salerno F, Gerbes A, Ginès P, et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis[J]. Gut, 2007, 56(9):1310-1318. [3] Nadim M K, Kellum J A, Forni L, et al. Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting[J]. J Hepatol, 2024, 81(1):163-183. [4] Lungu A, Sarbu G E, Cotlet A S, et al. Acute kidney injury in patients with liver cirrhosis: from past to present definition and diagnosis[J]. Life (Basel), 2025, 15(8):1249. [5] Simbrunner B, Trauner M, Reiberger T, et al. Recent advances in the understanding and management of hepatorenal syndrome[J]. Fac Rev, 2021, 10:48. [6] Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group[J]. Crit Care, 2004; 8(4): R204-212. [7] Mehta R L, Kellum J A, Shah S V, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury[J]. Crit Care, 2007, 11(2): R31. [8] Kidney disease: improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for acute kidney injury[J]. Kidney Int Suppl, 2012, 2(1):1-138. [9] Summary of recommendation statements[J]. Kidney Int Suppl (2011), 2012: 2(1): 8-12. [10] Levey A S. Defining AKD: the spectrum of AKI, AKD, and CKD[J]. Nephron, 2022, 146(3):302-305. [11] Kidney disease: improving global outcomes (KDIGO). KDIGO 2012 Clinical Practice Guideline for the evaluation and management of chronic kidney disease[J]. Kidney Int Suppl. 2013, 3:1-150. [12] Chawla L S, Bellomo R, Bihorac A, et al. Acute kidney disease and renal recovery: consensus report of the acute disease quality initiative (adqi) 16 workgroup[J]. Nat Rev Nephrol. 2017, 13:241-257. [13] Angeli P, Garcia-Tsao G, Nadim M K, et al. News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document[J]. J Hepatol, 2019, 71(4): 811-822. [14] Levey A S, Eckardt K U, Dorman N M, et al. Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference[J]. Kidney Int, 2020, 97(6):1117-1129. [15] European Association for the Study of the Liver: EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis[J]. J Hepatol, 2018, 69(2): 406-460. [16] Csak T, Bernstein D. Hepatorenal syndrome: pathophysiology[J]. Clin Liver Dis, 2022, 26(2):165-179. [17] Badura K, Frąk W, Hajdys J, et al. Hepatorenal syndrome-novel insights into diagnostics and treatment[J]. Int J Mol Sci, 2023, 24(24):17469. [18] Angeli P, Gines P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites[J]. Gut, 2015, 64(4):531-537. [19] Nadim M K, Kellum J A, Davenport A, et al. Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group[J]. Crit Care, 2012,16(1): R23. |